[Current aspects of rheumatoid arthritis]. 1979

K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath

According to recent investigations two factors might play an essential role in the pathogenesis of rheumatoid arthritis (R.A.). Besides genetic components, i.e. the HLA-system and familial aggregation, the immune processes, mediating tissue inflammation and injury, are acknowledged as having established roles in the pathogenesis of R.A. The present report reemphasizes recent data concerning the autoimmunity and the immunologic network with trends of therapy in R.A. In view of the effectiveness of new nonsteroidal antiinflammatory drugs, a double-blind study of suxibuzon vs. indomethacin in 30 patients with active R.A. is described in detail. Both drugs were active and similar in their efficacy at 4 weeks as judged by clinical and laboratory measurements. No serious toxic side-effects were observed in both treatment regimens.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath
January 1978, Terapevticheskii arkhiv,
K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath
September 1963, Hospital (Rio de Janeiro, Brazil),
K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath
April 1991, Clinical orthopaedics and related research,
K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath
June 2010, Current opinion in pharmacology,
K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath
September 1975, Nursing times,
K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath
September 1975, Nursing times,
K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath
January 1997, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath
January 1990, Giornale di clinica medica,
K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath
January 2012, Terapevticheskii arkhiv,
K M Goebel, and E Hahn, and L Hausmann, and U Storck, and H Kaffarnik, and F Neurath
June 1971, Zeitschrift fur arztliche Fortbildung,
Copied contents to your clipboard!